BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
March 23, 2011
View Archived Issues
Genfit, Sanofi-Aventis Ink $54M Deal for Metabolic Disorders
Extending a partnership that dates back to 1999, Genfit, of Lille, France, has inked an agreement with Sanofi-Aventis SA, of Paris, to pursue therapies for the treatment of metabolic disorders. (BioWorld International)
Read More
Scotland Aims to Double its Life Sciences Sector by 2020
Read More
Agennix Finishes Recruitment for NSCLC Drug's Phase III
Read More
Ion Channel on Sperm Could Be Key to New Contraceptives
Read More
Transgene Sets Game Plan for Cancer Vaccine Post-Roche Exit
Read More
Amgen's BioVex Buy Prompts PsiOxus to Expand its Program
Read More
Other News To Note
Read More